Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase

Cellular and Molecular Gastroenterology and Hepatology - Tập 12 - Trang 1297-1310 - 2021
Shadi Salloum1, Andre J. Jeyarajan1, Annie J. Kruger1,2, Jacinta A. Holmes1,3, Tuo Shao1,4, Mozhdeh Sojoodi5, Myung-Ho Kim1, Zhu Zhuo6, Stuti G. Shroff7, Andrew Kassa1, Kathleen E. Corey1, Sanjoy K. Khan1, Wenyu Lin1, Nadia Alatrakchi1, Esperance A.K. Schaefer1, Raymond T. Chung1
1Liver Center, Massachusetts General Hospital, Boston, Massachusetts
2Department of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC
3Department of Gastroenterology, St. Vincent's Hospital, Fitzroy, Victoria, Australia
4Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, Massachusetts
5Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts
6Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
7Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

Tài liệu tham khảo

Williams, 2011, Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study, Gastroenterology, 140, 124, 10.1053/j.gastro.2010.09.038 Diehl, 2017, Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis, N Engl J Med, 377, 2063, 10.1056/NEJMra1503519 Kim, 2019, OPTN/SRTR 2017 Annual Data Report: liver, Am J Transplant, 19, 184, 10.1111/ajt.15276 Estes, 2018, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, 67, 123, 10.1002/hep.29466 Machado, 2015, Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease, J Hepatol, 63, 962, 10.1016/j.jhep.2015.05.031 Wang, 2016, Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis, Cell Metab, 24, 848, 10.1016/j.cmet.2016.09.016 Zhao, 2007, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control, Genes Dev, 21, 2747, 10.1101/gad.1602907 Mooring, 2019, Hepatocyte stress increases expression of yes-associated protein and transcriptional coactivator with PDZ-binding motif in hepatocytes to promote parenchymal inflammation and fibrosis, Hepatology, 0, 1 Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, 24, 908, 10.1038/s41591-018-0104-9 McPherson, 2015, Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management, J Hepatol, 62, 1148, 10.1016/j.jhep.2014.11.034 Nasr, 2018, Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies, Hepatol Commun, 2, 199, 10.1002/hep4.1134 Collins, 2006, p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes, J Biol Chem, 281, 24336, 10.1074/jbc.M602177200 Liu, 2007, Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase, J Biol Chem, 282, 14205, 10.1074/jbc.M609701200 Lei, 2008, TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway, Mol Cell Biol, 28, 2426, 10.1128/MCB.01874-07 Oh, 2008, In vivo regulation of Yorkie phosphorylation and localization, Development, 135, 1081, 10.1242/dev.015255 Farrell, 2019, Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis, Hepatology, 69, 2241, 10.1002/hep.30333 Neuschwander-Tetri, 2010, Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites, Hepatology, 52, 774, 10.1002/hep.23719 Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Nat Rev Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38 Zhang, 2010, The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals, Dev Cell, 19, 27, 10.1016/j.devcel.2010.06.015 González-Terán, 2016, p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration, EMBO J, 35, 536, 10.15252/embj.201591857 Johnson, 2002, Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases, Science, 298, 1911, 10.1126/science.1072682 Bian, 2013, CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice, J Lipid Res, 54, 44, 10.1194/jlr.M026013 Huang, 2016, Regulation of Hippo signalling by p38 signalling, J Mol Cell Biol, 8, 328 Yimlamai, 2014, Hippo pathway activity influences liver cell fate, Cell, 157, 1324, 10.1016/j.cell.2014.03.060 Mannaerts, 2015, The Hippo pathway effector YAP controls mouse hepatic stellate cell activation, J Hepatol, 63, 679, 10.1016/j.jhep.2015.04.011 Song, 2020, Yes-associated protein in Kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis, Hepatology, 0, 1 Almpanis, 2016, Evaluation of liver fibrosis: “something old, something new….”, Ann Gastroenterol, 29, 445 Kitani, 2011, A Simple and efficient method to isolate macrophages from mixed primary cultures of adult liver cells, J Vis Exp, 1 Foty, 2011, A simple hanging drop cell culture protocol for generation of 3D spheroids, J Vis Exp, 20, 4 Salloum, 2016, Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types, Hepatology, 64, 1951, 10.1002/hep.28766